1. A reply to "Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model". (January 2021) Authors: Moldaver, Daniel; Hurry, Manjusha; Evans, William K.; Cheema, Parneet K.; Sangha, Randeep; Burkes, Ronald; Melosky, Barbara; Tran, Diana; Boehm, Darryl; Venkatesh, Jaya; Walisser, Susan; Orava, Erik; Grima, Daniel Journal: Lung cancer Issue: Volume 151(2021) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence with capecitabine: A population-based analysis based on prescription refill data. (June 2017) Authors: Kovacic, Laurel; de Haan, Neil; de Lemos, Mário L; Schaff, Kimberly; Walisser, Susan Journal: Journal of oncology pharmacy practice Issue: Volume 23:Number 4(2017) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation. (January 2018) Authors: de Lemos, Mário L; Markarian, Adeline; Chan, Esther; Schaff, Kimberly; Walisser, Susan Journal: Journal of oncology pharmacy practice Issue: Volume 24:Number 1(2018) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model. (January 2020) Authors: Moldaver, Daniel; Hurry, Manjusha; Evans, William K.; Cheema, Parneet K.; Sangha, Randeep; Burkes, Ronald; Melosky, Barbara; Tran, Diana; Boehm, Darryl; Venkatesh, Jaya; Walisser, Susan; Orava, Erik; Grima, Daniel Journal: Lung cancer Issue: Volume 139(2020) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗